SIRT1 and acute kidney injury: Given SIRT1’s established role in mitigating hypoxia-related renal injury and oxidative stress [4,5], we designed this study to evaluate whether serum SIRT1 levels could serve as an early biomarker for CI-AKI in patients undergoing PCI.